Skip to main content
B

BigOHealth

BigOHealth is a telemedicine platform that provides rural Indians with access to primary, specialist, and tertiary healthcare services through online appointment booking, video consultations, and diagnostic tests. The app addresses the significant barriers of long travel distances and extended wait times for medical care, ensuring timely and affordable healthcare delivery.

New Delhi, IndiaFounded 2020142K+ followers
Updated 20 months ago

Funding

Funding not disclosed

SH
Funding rounds are not available yet.

Founders

Product

Problem

Rural populations in India face significant barriers to accessing healthcare, including long travel distances, extended wait times, and a shortage of medical specialists in their local areas. This results in delayed diagnoses, inadequate treatment, and poorer health outcomes for those living in remote regions.

Solution

BigOHealth is a telemedicine platform that connects patients in rural India with primary care physicians, specialists, and tertiary care services through online appointment booking and video consultations. The platform eliminates the need for arduous journeys and lengthy waits outside clinics, offering convenient and affordable healthcare access. Patients can also book diagnostic tests and receive follow-up care remotely, ensuring continuity of treatment.

Target Audience

The primary target audience is individuals residing in tier-3 and tier-4 towns and rural areas of India who lack convenient access to quality healthcare services.

Features

  • Online appointment booking with doctors and hospitals
  • 24/7 teleconsultation and video consultation with doctors
  • Option to book lab tests and scans from home
  • Digital storage of medical records for easy access
  • Health tips and expert advice on various health topics
  • Health discussion channel for patients to discuss health and fitness topics
  • Multilingual support, including Hindi, to cater to rural populations
This profile is AI-generated and may contain inaccuracies.